Open AccessUndertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset
Author(s) -
Jordi Monés,
Rishi P. Singh,
Francesco Bandello,
Eric H. Souied,
Xin Liu,
Richard Gale
Publication year - 2019
Publication title -
ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.639
H-Index - 60
eISSN - 1423-0267
pISSN - 0030-3755
DOI - 10.1159/000502747
Subject(s) - mindset , medicine , macular degeneration , virtuous circle and vicious circle , clinical trial , visual acuity , intensive care medicine , clinical practice , ophthalmology , physical therapy , philosophy , epistemology , economics , macroeconomics
To assess the gap between visual acuity (VA) outcomes with anti-vascular endothelial growth factor (anti-VEGF) therapies in clinical trials and real-world practice, and explore the reasons for this gap.